Oxford–AstraZeneca COVID-19 vaccine

The National Committee for Vaccination against COVID-19 (CNCAV) informs that, in the past 24 hours, 58,062 persons received vaccination doses, out of which 45,356 Pfizer, 4,369 Moderna and 8,337 AstraZeneca, according to data released by the National Public Health Institute (INSP) through the National Electronic Vaccination Registry.

The National Committee for Vaccination against COVID-19 (CNCAV) informs that, in the past 24 hours, 47,196 persons received vaccination doses, out of which 35,850 Pfizer, 4,023 Moderna and 7,323 AstraZeneca, according to data released by the National Public Health Institute (INSP) through the National Electronic Vaccination Registry.

Serbia, champion of the vaccination process in the Balkans, has donated thousands of jabs to its neighbours, including Bosnia and Herzegovina, North Macedonia and Montenegro.

Albania recently started doing the same, helping Kosovo, the only country in the region that did not start its vaccination process at all.

The EMA found no evidence of a link between the vaccine and the overall risk of blood clots

Ljubljana – Slovenia did not opt for an optional offer by the Pfizer/BioNTech and Moderna vaccines as part of joint EU purchasing because the deliveries were expected as late as in the second half of 2021, the Health Ministry told the STA on Sunday. The country expressed interest in acquiring vaccine volumes on a pro rata basis, it added.

The National COVID Vaccination Coordination Committee (CNCAV) announced Friday the decision to cancel the suspension of the Oxford/AstraZeneca vaccine batch ABV 2856.

Vaccination with the AstraZeneca vaccine may continue in all EU countries from tomorrow, Bogdan Kirilov, executive director of the Bulgarian Drug Agency said on March 18.

He added that there is an official statement which confirms the effectiveness of the vaccine and there is no problem to continue using it.

Ljubljana – Slovenia has decided to resume using the AstraZeneca vaccine after the European Medicines Agency (EMA) assessed AstraZeneca’s Covid-19 vaccine “safe and effective” after a review of possible blood clot risks.

No link has been found between the AstraZeneca vaccine and thrombosis by the PRAC Committee of the European Medicines Agency (EMA). It is still unclear whether there is a link between very rare forms of thrombosis and the vaccine.

It is still unclear whether there is a link between very rare forms of thrombosis and the vaccine.

The national committee for vaccinating against COVID (CNCAV) informs that within the last 24 hours there were 51,925 vaccine doses administered, of which 38,613 - Pfizer, 6,369 - Moderna and 6,943 - AstraZeneca, according to the data published by the National Institute of Public Health (INSP), through the National Electronic Vaccination Registry.